{"id":"https://openalex.org/W1971998101","doi":"https://doi.org/10.1016/j.jalz.2009.04.241","title":"P1\u2010234: Pharmacological and behavioral profile of EVP\u20105141, a novel \u03b17 nicotinic acetylcholine receptor agonist","display_name":"P1\u2010234: Pharmacological and behavioral profile of EVP\u20105141, a novel \u03b17 nicotinic acetylcholine receptor agonist","publication_year":2009,"publication_date":"2009-06-25","ids":{"openalex":"https://openalex.org/W1971998101","doi":"https://doi.org/10.1016/j.jalz.2009.04.241","mag":"1971998101"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2009.04.241","doi":"https://doi.org/10.1016/j.jalz.2009.04.241","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2009.04.241","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028557857","display_name":"Frank Boess","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110958","display_name":"Eli Lilly (Germany)","ror":"https://ror.org/01pmvz131","country_code":"DE","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210110958"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Frank Boess","raw_affiliation_strings":["Bayer Healthcare AG, Wuppertal, Germany","Lilly Deutschland, Bad Homburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Lilly Deutschland, Bad Homburg, Germany","institution_ids":["https://openalex.org/I4210110958"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066903149","display_name":"Jean De Vry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jean de Vry","raw_affiliation_strings":["Bayer Healthcare AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081197851","display_name":"Christina Erb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christina Erb","raw_affiliation_strings":["Bayer Healthcare AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044280551","display_name":"Timo Fle\u00dfner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Timo Flessner","raw_affiliation_strings":["Bayer Healthcare AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113616244","display_name":"Martin Hendrix","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Hendrix","raw_affiliation_strings":["Bayer Healthcare AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014504073","display_name":"Joachim E. A. Luithle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Joachim Luithle","raw_affiliation_strings":["Bayer Healthcare AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019624032","display_name":"Christoph Methfessel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christoph Methfessel","raw_affiliation_strings":["Bayer Healthcare AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078801509","display_name":"Katrin Schnizler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Katrin Schnizler","raw_affiliation_strings":["Bayer Healthcare AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022063104","display_name":"F. Josef van der Staay","orcid":"https://orcid.org/0000-0002-8704-3366","observed_orcids":["https://orcid.org/0000-0002-8704-3366"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"F. Josef van der Staay","raw_affiliation_strings":["Bayer Healthcare AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111892964","display_name":"Marja van Kampen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Marja van Kampen","raw_affiliation_strings":["Bayer Healthcare AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032605199","display_name":"Welf\u2010Burkhard Wiese","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Welf\u2010Burkhard Wiese","raw_affiliation_strings":["Bayer Healthcare AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Healthcare AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015447874","display_name":"Gerhard Koenig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270511","display_name":"FORUM Pharmaceuticals (United States)","ror":"https://ror.org/00v0h1b27","country_code":"US","type":"company","lineage":["https://openalex.org/I4405270511"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerhard Koenig","raw_affiliation_strings":["EnVivo Pharmaceuticals, Watertown, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EnVivo Pharmaceuticals, Watertown, MA, USA","institution_ids":["https://openalex.org/I4405270511"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5028557857"],"corresponding_institution_ids":["https://openalex.org/I4210110958","https://openalex.org/I67348948"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.09437803,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"4S_Part_8","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alpha7-nicotinic-acetylcholine-receptor-agonist","display_name":"\u03b17 nicotinic acetylcholine receptor agonist","score":0.9430000185966492}],"concepts":[{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.8361427187919617},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5739225745201111},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5734796524047852},{"id":"https://openalex.org/C188987157","wikidata":"https://www.wikidata.org/wiki/Q7030581","display_name":"Nicotinic agonist","level":3,"score":0.5417014956474304},{"id":"https://openalex.org/C80161118","wikidata":"https://www.wikidata.org/wiki/Q408520","display_name":"Acetylcholine receptor","level":3,"score":0.5182997584342957},{"id":"https://openalex.org/C2780374058","wikidata":"https://www.wikidata.org/wiki/Q3333710","display_name":"Methyllycaconitine","level":5,"score":0.47316962480545044},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47012412548065186},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.4619484543800354},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.435272216796875},{"id":"https://openalex.org/C51927110","wikidata":"https://www.wikidata.org/wiki/Q4734895","display_name":"Alpha-4 beta-2 nicotinic receptor","level":5,"score":0.42454805970191956},{"id":"https://openalex.org/C2779570518","wikidata":"https://www.wikidata.org/wiki/Q412256","display_name":"Nicotinic acetylcholine receptor","level":4,"score":0.40856319665908813},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.32478228211402893},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26738297939300537},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2009.04.241","doi":"https://doi.org/10.1016/j.jalz.2009.04.241","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2009.04.241","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8999999761581421}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1991367061","https://openalex.org/W2071608242","https://openalex.org/W2120349084","https://openalex.org/W2150790731","https://openalex.org/W3158317174","https://openalex.org/W3002687532","https://openalex.org/W1965386908","https://openalex.org/W2016729909","https://openalex.org/W1568332152","https://openalex.org/W2014699148"],"abstract_inverted_index":{"Agonists":[0],"at":[1,44,142,156,166],"\u03b17":[2,22,29,106,148,218,223,319],"nicotinic":[3],"acetylcholine":[4],"receptors":[5,81,121],"(nAChRs)":[6],"may":[7,226,322],"have":[8],"therapeutic":[9,326],"potential":[10],"for":[11,130,328],"the":[12,20,87,143,157,167,178,210,217,229,236,258,316,329],"treatment":[13,330],"of":[14,19,64,89,97,177,232,245,272,331],"cognitive":[15,332],"deficits.":[16],"The":[17,59],"effect":[18],"novel":[21,325],"nAChR":[23,30,107,169,219,224,320],"agonist":[24,141,154,164],"EVP-5141":[25,65,90,103,137,172,204,249,264,284,301],"on":[26],"\u03b14\u03b22":[27,75,131,186],"and":[28,39,62,76,79,94,99,116,146,160,187,220,291,307,313,336],"in":[31,50,55,68,83,91,108,235,257,262,275,295,304,310,334],"rat":[32,109,145,237],"brain":[33,110],"membranes":[34,111],"was":[35,53,66,138,241],"determined":[36,67],"using":[37,71],"[H]cytisine":[38],"[H]methyllycaconitine":[40],"binding":[41,57],"assays.":[42,58],"Affinity":[43],"recombinant":[45,72,118,144],"human":[46,119,147],"5-HT3":[47,80,120,158,179],"receptor":[48,159,180],"expressed":[49,82],"HEK293":[51],"cells":[52],"measured":[54],"[H]GR65630":[56],"functional":[60],"potency":[61],"selectivity":[63],"electrophysiological":[69],"assays":[70],"\u03b17,":[73],"\u03b13\u03b24,":[74,185],"muscle":[77,188],"nAChRs":[78,132],"Xenopus":[84],"oocytes.":[85],"Subsequently":[86],"effects":[88],"drug":[92],"discrimination":[93],"several":[95,305],"tests":[96,309],"learning":[98,306],"memory":[100,271,294,308],"were":[101],"determined.":[102],"bound":[104],"to":[105,117,192,203],"(Ki":[112,122,133],"=":[113,123],"270":[114],"nM)":[115],"880":[124],"nM),":[125],"but":[126,150,181],"had":[127],"low":[128],"affinity":[129],">":[134],"100":[135],"\u03bcM).":[136],"a":[139,276,324],"potent":[140],"nAChR,":[149],"did":[151,182,200],"not":[152,183,201,214,227],"show":[153],"activity":[155,165],"no":[161],"or":[162],"weak":[163],"other":[168],"subtypes":[170],"tested.":[171],"acted":[173],"as":[174],"an":[175],"antagonist":[176],"block":[184],"nAChR.":[189],"Rats":[190],"trained":[191],"discriminate":[193],"nicotine":[194,211],"(0.4":[195],"mg/kg,":[196,206,266],"s.c.)":[197],"from":[198],"vehicle":[199],"generalize":[202],"(0.3-30":[205],"p.o.)":[207,252,290],"suggesting":[208],"that":[209,221,318],"cue":[212],"is":[213],"mediated":[215],"by":[216],"selective":[222],"agonists":[225,321],"share":[228],"abuse":[230],"liability":[231],"nicotine.":[233],"Performance":[234],"social":[238,292],"recognition":[239,293],"test":[240],"improved":[242,268,285,302],"after":[243],"administration":[244],"0.3-3":[246],"mg/kg":[247,251,289],"EVP-5141.":[248],"(0.3":[250,288],"antagonized":[253],"scopolamine-induced":[254],"retention":[255],"deficits":[256,333],"passive":[259],"avoidance":[260],"task":[261],"rats.":[263],"(1":[265],"i.p.)":[267],"spatial":[269],"working":[270],"aged":[273],"rats":[274,312],"water":[277],"maze":[278],"repeated":[279],"acquisition":[280],"task.":[281],"In":[282],"addition,":[283],"both":[286,311],"object":[287],"mice":[296,314],"(0.001":[297],"-":[298],"3":[299],"mg/kg).":[300],"performance":[303],"supporting":[315],"hypothesis":[317],"provide":[323],"strategy":[327],"Schizophrenia":[335],"Alzheimer's":[337],"Disease.":[338]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}